NFKB1 and injury: Conversely, the anti-inflammatory action has been suggested in an experimental mouse model of acute lung injury, in which miR-30a-5p reduced the extent of Lipopolysaccharides (LPS)-induced damage through the increase in cell viability and cell cycle progression, the reduction in cell apoptosis, the influence on NF-Kb pathway, and the increase in IκBα degradation [22].